<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11561">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01865006</url>
  </required_header>
  <id_info>
    <org_study_id>IUCTF-2013-01</org_study_id>
    <nct_id>NCT01865006</nct_id>
  </id_info>
  <brief_title>Phoniatric Evaluation and Comparison of Patients Who Underwent Sutureless Thyroidectomy With Vessel Closure Devices and Conventional Total Thyroidectomy With Suture</brief_title>
  <official_title>Phoniatric Evaluation and Comparison of Patients Who Underwent Sutureless Thyroidectomy With Vessel Closure Devices and Conventional Total Thyroidectomy With Suture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <authority>Turkey: Ethics Committee</authority>
    <authority>Turkey: Ministry of Health</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare effect of sutureless thyroidectomy with vessel
      closure devices and conventional thyroidectomy with suturing on voice quality with
      phoniatric evaluation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Voice quality change in relation with operative technique</measure>
    <time_frame>Postoperative 1st week and 2nd month</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Voice quality change between postoperative 1st week and 2nd month in relation with operative technique (either sutureless (with Ligasure or Ultracision) or conventional technique) via Voice handicap index, videolaryngostroboscope, CSL MDVP advanced software, and Glottography.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Voice quality change in relation with histopathology.</measure>
    <time_frame>1st week and 2nd month</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Voice quality change between postoperative 1st week and 2nd month in relation with histopathology via Voice handicap index, videolaryngostroboscope, CSL MDVP advanced software, and Glottography.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Phoniatric Evaluation of Total Thyroidectomy</condition>
  <arm_group>
    <arm_group_label>Ligasure LF1212</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultracision</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent to total thyroidectomy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Exclusion Criteria:

          -  Pre-operative voice problems

          -  Pre-operative vocal cord paralysis

          -  Singers and teachers

          -  Pre-operative known advanced stage malignity

          -  Previously operated for thyroid diseases.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Server Sezgin ULUDAG, MD</last_name>
    <phone>+905334933676</phone>
    <email>sszgn.uludag@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Istanbul University Cerrahpasa Medical Faculty Department of General Surgery</name>
      <address>
        <city>Istanbul</city>
        <zip>34098</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Server Sezgin ULUDAÄž, MD</last_name>
      <phone>+905334933676</phone>
      <email>sszgn.uludag@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Server Sezgin ULUDAG, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 26, 2013</lastchanged_date>
  <firstreceived_date>May 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Server Sezgin Uludag</investigator_full_name>
    <investigator_title>Resident</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
